Jun 17, 2026 06:50AM
May 20, 2026 08:00AM
May 1, 2026 08:00AM
Mar 4, 2026 05:46PM
Dec 11, 2025 04:05PM
Nov 4, 2025 08:00AM
Nov 4, 2025 08:00AM Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
Oct 25, 2025 09:59AM
Oct 25, 2025 09:59AM
Oct 23, 2025 08:00AM
Aug 7, 2025 06:59AM
Jun 16, 2025 08:01AM
Jun 16, 2025 08:00AM
Jun 9, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
Jun 9, 2025 05:15AM
Jun 6, 2025 01:46PM
Jun 6, 2025 12:48PM
Jun 6, 2025 12:28PM
Jun 6, 2025 12:27PM
Jun 6, 2025 11:51AM
May 1, 2025 07:00AM Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Apr 28, 2025 07:59AM
Apr 1, 2025 08:01AM
Apr 1, 2025 08:00AM
Mar 31, 2025 08:00AM
Mar 31, 2025 07:59AM
Mar 6, 2025 08:00AM
Feb 15, 2025 10:00PM Biotech Q4 earnings preview: Goldman Sachs
Feb 7, 2025 01:34PM
Dec 12, 2024 06:44AM
Dec 11, 2024 09:38AM
Dec 11, 2024 08:00AM
Nov 7, 2024 01:51PM
Nov 7, 2024 08:00AM
Oct 27, 2024 12:00PM Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting
Aug 8, 2024 08:00AM
Jul 30, 2024 08:02AM
Jul 30, 2024 08:00AM
Jul 19, 2024 10:02AM
Jul 18, 2024 08:01AM
Jul 18, 2024 08:00AM
May 15, 2024 08:00AM Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
May 9, 2024 08:00AM
Mar 26, 2024 08:00AM
Mar 7, 2024 08:00AM
Feb 13, 2024 08:00AM
Feb 13, 2024 08:00AM
Dec 14, 2023 08:00AM
Dec 6, 2023 08:00AM Phathom Pharma (PHAT) Announces FDA Acceptance for Filing of VOQUEZNA Tablets NDA for Treatment of Heartburn Associated with Non-Erosive GERD
Dec 6, 2023 08:00AM

323,579 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All